• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A method of rendering antiseptic a packaged solid admixed emulsion for treating bleeding cuts and the like containing, dispersed therein, a bactericidal component that is solid at room temperature, such as cinnamic alcohol, but melts or liquefies at blood temperature upon contacting the blood, comprising elevating the temperature of the packaged emulsion and/or contacting with moisture briefly to commence such liquefying to wet the exterior surface of the solid emulsion, and with concurrent release of bactericidal vapor within the package, and the resulting antiseptic solid emulsion products produced thereby.
    公开号:US20010006669A1
    申请号:US09/169,756
    申请日:1998-10-09
    公开日:2001-07-05
    发明作者:Robert H. Rines；R. David Rines
    申请人:Allor Foundation；
    IPC主号:A61L15-44
    专利说明:
    [0001] The present invention is directed to methods of and products for enabling the disinfecting or antiseptic protecting and substantially room temperature storing of normally dry bacterial-component-containing solid emulsions for pharmacological use with bleeding cuts, wounds, and abrasions and the like; being more particularly concerned with the rendering antiseptic during packaged or other storage of such dry solid emulsions of the type that start to melt, sublime or liquefy at somewhat higher than room temperature, (as of the order of the temperature of human or animal blood in living subjects—about 98-100° F.), upon being contacted by moisture, such as complexes of polyvinylpyrrolidone admixed with cinnamic alcohol and tannic acid, as described in U.S. Pat. Nos. 3,525,340 and 3,777,016 of Joseph G Gilbert, and in U.S. Pat. No. 4,094,967 of the Allor Foundation, common assignee of the present invention [0001] BACKGROUND
    [0002] In the first two of the above-referenced Gilbert patents, there is described a process of preparing such a solid emulsion complex of polyvinylpyrrolidone admixed with cinnamic alcohol and tannic acid (and with iodine admixed in the third patent), wherein the solid emulsion, as applied to a flexible or foam or other bandage substrate, or to a swab or in solid powder state, is applied to bleeding cuts (lacerations, wounds, etc) and abrasions and the like, and commences melting or liquefying from the exterior surfaces at the elevated temperature of the blood upon contacting the bleeding cut or the like This action releases the melting or liquefying active anti-bacterial cinnamic alcohol from the solid complex, and independently, active fungicidal tannic acid, that has been found remarkably to prevent infections; and, particularly through the film-forming and coagulation-binding of the polyvinylpyrrolidone, promotes rapid healing and, surprisingly, substantially without keloid formation [0002]
    [0003] Earlier culture tests demonstrating efficacy against pathological organisms, animal clinical tests, and substantial human subject clinical use are described particularly in the before-cited U.S. Pat. No. 3,777,016. [0003]
    [0004] Because of the elevated-temperature-induced and/or moisture liquefying release and/or subliming by the blood in the wound of the bactericidal component (cinnamic alcohol) at the exterior surface of the solidified emulsion product upon use, it was thought that concerns about antiseptic packaging were no longer necessary This had been considered a radically new feature of this novel product in that it did not have to be kept sterile or even packaged, because, substantially instantaneously upon use, the wound was immersed in released bacterial liquid melted from the solid emulsion—and, indeed, as stressed in the first two of the above patents, it was found no longer necessary, from an infection point of view, to be concerned even with careful cleansing of the skin at the wound area before applying the dressing [0004]
    [0005] In retrospect, however, this turned out to be too radical a concept for acceptance by the medical and health-care-providing community which had and has the ingrained concept of universal aseptic products and packaging whether really needed or not. The terms “packaging” and “package” are herein generically used to embrace envelopes, wrappings and other containments or coverings. [0005]
    [0006] But the nature of this type of heat and moisture meltable or liquefying solidified emulsion complex, unfortunately, did not lend itself to any of the conventional high temperature auto-claving, ethylene oxide treatment, extended ultra violet, or other aseptic packaging and storing techniques customarily used for other products, in view of the deleterious physical and chemical effects of such procedures upon such emulsions It was not until the discovery underlying the present invention, indeed, that an effective and inexpensive disinfecting or antiseptic packaging technique was finally evolved, that is particularly tailored to, and inherently self-generating with the heat- and moisture-meltable or liquefying characteristics of the room temperature dry solid emulsion products hereinvolved; requiring no autoclaves or similar conventional sterilizing technique treatments, and that now promises to make these products commercially acceptable in the health-care industry [0006] OBJECTS OF INVENTION
    [0007] It is accordingly an object of the present invention to provide a new and improved method of rendering such bactericidal-component-containing solid emulsion complexes antiseptic along their exposed surfaces and/or within packages enclosing the same, and providing resulting novel antiseptic solid emulsions [0007]
    [0008] Other and further objects will be explained hereinafter and are more fully delineated in the appended claims. [0008] SUMMARY
    [0009] In summary, from one of its important aspects, the invention embraces in the preparation of a normally room-temperature-stored package containing a normally dry bactericidal-component-dispersed solid emulsion complex (such as a cinnamic alcohol component, for example) for pharmacological use with bleeding cuts and abrasions and that remains solidified at room temperature and below and so long as it is not contacted by moisture, but that starts to liquefy at somewhat higher temperature of the order of the temperature of human or animal blood in a living subject upon application of moisture thereupon, a method of rendering antiseptic both the exposed surface of the solidified emulsion and the interior of the package, that comprises, treating the interior of the package with one or both of increased temperature, at least to said higher temperature, and applied moisture to said exposed surface; and, doing so only for a time interval that is limited to the time required for the commencement of liquefying of said component sufficiently to wet the exposed surface of the solidified emulsion from which the component is drawn, and with a concurrent resulting commencement of release of bactericidal vapor therefrom, and returning the package to room temperature, and sealing the package from further moisture, to enable the drying and re-solidifying of the exposed surface of the emulsion after having been thus wetted with the bactericidal component liquid drawn therefrom, and with the interior of the package having been exposed to the released bactericidal vapor [0009]
    [0010] Preferred and best mode techniques, modifications and products will be described hereinafter in detail. [0010] DRAWINGS
    [0011] The invention will now be described in connection with the accompanying drawings, [0011]
    [0012] FIGS. 1A and 1B and [0012] 2A and 2B of which are photographic reproductions of bacteria-contaminated emulsion complex and antiscepticized emulsion complex surfaces of samples A and B, respectively, showing the sterilization by the process of the invention, and
    [0013] FIGS. 3A and 3B are zone of inhibition photographs further illustrating the sterilizing effects of the invention on samples A and B [0013] PREFERRED EMBODIMENT(S)
    [0014] Underlying the present invention, is the discovery that, by causing the commencement of melting (including some sublimation) or liquefying—these words being used substantially synonymously herein—at the exposed surface of the bactericidal-component-containing solid admixed emulsions of the above-described type with which the present invention is concerned, as by short and slight temperature rise to the melting temperature of said component, and upon introduced moisture contact, as by steam or otherwise, bactericidal liquid starts to be drawn from and released through the exposed surface, wetting the same, this liquefying wetting process also releasing some vapor phase bactericidal vapor adjacent such surface and within the interior of the package in which the solid emulsion product may be contained By terminating the heat/moisture and its surface liquefying and vapor release just after the commencement thereof, (as by rapidly removing or lowering the temperature and/or sealing against further moisture), and thus restoring the emulsion to its normal solid room-temperature dry state within the package, the exterior surface becomes totally re-solidified, but now with a self-generated antiseptic bactericidal coating on its exposed surface, and the interior of the package has been rendered antiseptic by the exposure to the antiseptic bactericidal vapor released therein during and as a result of the short-period melting transition from solid to liquid (wetting). [0014]
    [0015] More specifically, the before-described solid emulsions of admixed polyvinylpyrrolidone—cinnamic acid—tannic acid (and/or iodine) have been successfully so rendered antiseptic both for containment in packages and without packages by this technique of the invention [0015]
    [0016] While as shown in above-cited patents, the complex of the invention is effective against a wide range of microorganisms for purposes of hereinafter described tests, [0016] E. coli was selected for illustrative use because of its current tenacity and pervasive problems, though the effects herein have also been observed on other microorganisms, including as described in said patents EXAMPLE 1
    [0017] A sample solid emulsion of the above-described type (sample A) was prepared in the manner described in said Gilbert patents A mixture was prepared from 2 92 g tannic acid powder U S P, 0.71 g cinnamic alcohol powder, and 28 32 g. polyvinylpyrrolidone sold by the GAF corporation under the trade designation K29-32, that is, a mixture of about 8 8 parts tannic acid, about 2.1 parts cinnamic alcohol, and about 85 parts polyvinylpyrrolidone, by weight The mixture was dissolved in 22 5 ml. water during agitation in a Waring blender, and the resulting viscous, yellowish solution was spread with a spatula over one side of a {fraction (3/32)} inch thick white foam rubber webbing About 29 6 ml solution covered about 258 cm[0017] 2 of the substrate. After drying at room temperature, a thin, pale-yellowish, dry-to-touch film was obtained as the residue of the solution. (Such coated foam rubber webbing was earlier successfully used by Dr Gilbert in the infirmary of a manufacturing plant for the successful treatment of over 160 lacerations of varying sizes and types)
    [0018] Sample A was exposed for at least several months to the atmosphere without any packaging It was then subjected briefly to steam until the surface was observed to start to liquefy or become wet and a distinctive “cinnamon” vapor was released (from 30 seconds to 5 minutes) After drying in air, the sample was swabbed over a tryptone and yeast extract agar growth medium (luria broth—LB extract) It was then incubated at 37° C. overnight No bacterial growth was observed. [0018] EXAMPLE 2
    [0019] The preparation technique, of Example 1 was used in a sample B prepared with iodine crystals in an alcohol base (ethanol) added to the mixture before drying, as taught in before-mentioned U.S. Pat. No. 4,094,967, namely, polyvinylpyrrolidone K30 (28 349 grams) was dissolved in 19 cc of water by agitation, using slow mixing Finely powdered crystalline iodine (1 gram) was dissolved in 15 cc of 95% alcohol (ethanol) and added to the wetted (emulsified) polyvinylpyrrolidone and slowly mixed thoroughly 2 grams of liquid cinnamic alcohol (solid form melted at about 100° F.) was added to the above and slowly agitated Powdered tannic acid (2 grams) was then added to the above and mixed uniformly therein to form an emulsion The emulsion was then uniformly spread on a polyester dressing about 36 inches square and was permitted to air dry at substantially room temperature to evaporate the solvents and moisture to form an adherent unitary solid coating [0019]
    [0020] Sample B, after standing for at least several months exposed to the atmosphere without any packaging, was briefly steamed to the commencement of surface liquification and cinnimac alcohol vapor release and then dried, swabbed over the agar of Example 1 and incubated overnight No bacterial growth was observed [0020] EXAMPLES 3 AND 4
    [0021] The same protocols described under Examples 1 and 2 for samples A and B, were performed, but with each sample intentionally contaminated with 10 μl of [0021] E. coli before steam surface liquefying and vapor release, drying and swabbing over the agar. No growth was observed for either samples A or B. EXAMPLES 5 AND 6
    [0022] The same protocol with two pieces each of samples A and B contaminated with 50 μl of log-phase bacterial culture of [0022] E. coli (i.e live growing bacteria). One piece of each of samples A and B was used as a control and swabbed over the agar without liquefying activation A considerable lawn of bacterial growth was found to develop during overnight incubation, as shown in FIG. 1 A for control sample A and FIG. 2A for control sample B. The other pieces of each of samples A and B, so contaminated, were activated by brief steam surface liquefying, allowing the liquid coating to dry, with the coating sealing the surface, and then swabbed over the agar No bacterial growth whatsoever was observed during or after the overnight incubation, as shown in FIG. 1B for activated sample A and FIG. 2B for sample B.
    [0023] These experiments demonstrated that the brief steam (heat-moisture) surface-liquification process sterilized the surface of the bandages. They did not, of themselves, however, demonstrate whether the heat itself played any part in inhibiting the bacterial growth as distinguished from the bactericidal effect of the liquefied cinnamic alcohol released at and wetting the surface [0023] EXAMPLES 7 AND 8
    [0024] To ascertain the answer to this question, the tested samples A and B of experiments 3 and 4 were then re-activated to surface liquification commencement, and were then applied to agar plates growing [0024] E. coli and which were not subjected to steam or other heat. Zones of inhibition clearly and sharply developed around both bandage samples, A and B (FIGS. 3A and 3B) These indicated two results one, that the observed bactericidal sterilizing property of the surface-liquefying process was inherent to and solely caused by the release of the bactericidal component upon liquification and vapor release of the cinnamic alcohol-bound-surface and not to exposure to heat, and secondly, that the thusly sterilized bandage can be readily re-used with retained bactericidal efficacy
    [0025] This discovery enables repeated sterilizations of exposed emulsion surfaces, whenever desired, and without any degrading of the bactericidal efficacy for use on cuts and wounds when needed Where packaged, re-sterilization of packages inadvertently torn or opened is thus also readily achievable. [0025] EXAMPLE 9
    [0026] Bandage strips like sample A, about 2″ long by ½″ wide were cut and inserted in closely fitting paper envelope packages of but slightly larger dimensions, and sealed with external tape (Self or pressure-release adhesive flaps could have been used.) [0026]
    [0027] The packaged dry solid-emulsion coated strips were then, in accordance with the present invention, heated with a hair-dryer-type blower until it was observed that the exterior coating surface was becoming slightly wet or moist, starting some melting or liquefying, demonstrated in Examples 1, 3 and 5 to achieve self-sterilization (FIGS. 1B and 3A) The distinct odor of cinnamic alcohol vapor was again immediately noticed, demonstrating the release of such bactericidal vapor within the package and permeating the interior of the paper package [0027]
    [0028] The heat was thereupon removed and the packages allowed rapidly to cool back to room temperature (more slowly in air, and more rapidly by a short stay in the refrigerator) with the melted or liquefied wetting coating formed on and from the emulsion appearing totally re-solidified and dry, and with the surface sealed by the coating [0028] EXAMPLE 10
    [0029] Samples prepared as in Example 1, above, (sample A), were placed in the paper packages after being subjected to a fine spray of water (droplets on the emulsion) and slightly rubbed against the emulsion Commencement of oozing of cinnamic alcohol from the complex to the surface, was again observed, accompanied by its vapor phase release, evident by smell The packages were then externally sealed by taping to insure no further introduction of moisture. Both standing and accelerated drying with a blast of heat returned the emulsion to its dry state once more, with the wetted coating dried thereon, and providing the same antiseptic results as in Example 6 [0029] EXAMPLE 10
    [0030] The procedure of Example 9 was repeated, but, in addition to the slight moisturizing, heat was also applied from the hair dryer for a few seconds, accelerating the commencement of release of liquefied cinnamic alcohol and its vapor [0030]
    [0031] Once the packaged solid emulsion is rendered antiseptic as above described, it may be stored at room temperature until the bandage is to be used, whereupon the package is opened and the coated bandage is ready for use, as in the manner reported in the last-named patent In the use of sample B, for example, placing the coating on a bleeding wound has been found to melt the solidified cinnamic alcohol and release active iodine, active anti-bacterial cinnamic alcohol, and independently active fungicidal tannic acid Tests for the continuous slight heat and/or moisture release of these ingredients were performed, with the following simple visual and olfactory observations demonstrating the above, to wit, rubbing the moist coating on a starch-containing paper shows the purple active iodine, the yellow tannic acid, and with the aromatic characteristics of the cinnamic alcohol being clearly evident [0031] EXAMPLE 11
    [0032] The process of Example 10 was repeated without the tannic acid [0032] EXAMPLE 12
    [0033] The antiscepticizing processes of Examples 1-4 may be carried out with solid emulsion constituent weight proportion ranges of substantially the following. polyvinylpyrrolidone, 82-90%, cinnamic alcohol, 3-15%, and tannic acid, 3-12%, and, for Examples 2 and 4, iodine ½-3% [0033] EXAMPLE 13
    [0034] The process of Example 1 was repeated (sample A), but with the solid emulsion coating formed on a ceramic surface and then ground thereupon to form a fine powder of solid particles, sealed in the paper package, and rendered antiseptic as above. [0034] EXAMPLE 14
    [0035] Example 10 was repeated but with the solid emulsion complex formed as a coating at and sealing the end of a swab and sealed in the package [0035] EXAMPLE 15
    [0036] The materials as in Examples 1-4, samples A and B, were treated without the use of individual packages, but with the moisture (and heat) applied, and either dried or left moist, before use of the product to provide an antiseptic outer surface [0036]
    [0037] While the above preferred constituents have been found very effective, for various therapeutic purposes, additional and/or substitute components may, as taught in U.S. Pat. No. 3,777,016, be employed including, for example, substituting for an equal amount of polyvinylpyrrolidone, 0.25-1 parts by weight, (preferably about 0 5 part by weight, solid basis) of cortisone or cortisone derivative to promote healing, 0 5-2 parts by weight, (preferably about 0 7 part by weight, solids basis), of benzocaine or xylocaine to obtain increased analgesic action; and 0.04-0 09 part by weight, solid basis of benzalkonium chloride, if supplementation is desired, of the antibacterial action of the basic active composition [0037]
    [0038] Clearly, other types of packages and package materials and formats may be employed for the solid emulsion complexes of the invention and may similarly be rendered antiseptic, or the products may be otherwise stored for use and rendered antiseptic before use; and other modifications will also suggest themselves to those skilled in the art, such being considered to fall within the spirit and scope of the invention as defined in the appended claims. [0038]
    权利要求:
    Claims (31)
    [1" id="US-20010006669-A1-CLM-00001] 1. In the preparation of a normally room-temperature-stored package containing a normally dry bactericidal-component-dispersed solid emulsion complex for pharmacological use with bleeding cuts and abrasions, and that remains solidified at room temperature and below and so long as it is not contacted by moisture, but that starts to liquefy at somewhat higher temperature of the order of the temperature of human or animal blood in a living subject and upon application of moisture thereupon, a method of rendering antiseptic both the exposed surface of the solidified emulsion and the interior of the package, that comprises, treating the interior of the package with one or both of increased temperature, at least to said higher temperature, and moisture applied to said exposed surface, and, doing so only for a time interval that is limited to the time required for the commencement of liquefying of said component to wet the exposed surface of the solidified emulsion from which the component is drawn, and with a concurrent resulting commencement of release of bactericidal vapor phase therefrom, and returning the package to room temperature and sealing the package from further moisture, to enable the re-solidifying coating of the exposed surface of the emulsion after having been thus wetted with the bactericidal component liquid drawn therefrom, and with the interior of the package having been exposed to the released bactericidal vapor
    [2" id="US-20010006669-A1-CLM-00002] 2. In the preparation of a normally room-temperature-stored package containing a bactericidal-component-dispersed solid emulsion for pharmacological use with bleeding cuts and abrasions and that remains solidified at room temperature and below, but starts to liquefy at a somewhat higher temperature of the order of the temperature of human or animal blood in a living subject, a method of rendering antiseptic both the exposed surface of the solidified emulsion and the interior of its package, that comprises, raising the temperature of the package interior at least to said higher temperature, but only for a time interval that is limited to the time required for commencement of liquefying of said component at the solidified emulsion exposed surface and with the concurrent resulting commencement of release of bactericidal vapor phase therefrom, and thereupon returning the package to room temperature to re-solidify the surface of the emulsion after having been thus wetted with bactericidal component liquid drawn therefrom, and with the interior of the package exposed to the released bactericidal vapor
    [3" id="US-20010006669-A1-CLM-00003] 3. In the preparation of a normally room-temperature-stored package containing a normally dry bactericidal-component-dispersed solid emulsion for pharmacological use with bleeding cuts and abrasions and that remains solidified at room temperature and below, but starts to liquefy when moisture is applied thereto, a method of rendering antiseptic both the exposed surface of the solidified emulsion and the interior of the package, that comprises, applying moisture to said exposed surface before sealing the package, but only sufficient moisture and for a sufficiently short time to start the commencement of liquefying of said component at the solidified emulsion exposed surface, and with the concurrent resulting commencement of release of bactericidal vapor phase therefrom, and sealing the package from further moisture to enable the re-solidifying of the exposed surface of the emulsion after having been thus wetted with bactericidal component liquid drawn therefrom, and with the interior of the package exposed to the released bactericidal vapor.
    [4" id="US-20010006669-A1-CLM-00004] 4. The method as claimed in
    claim 1 wherein said solidified emulsion is formed by dissolving a mixture comprising polyvinylpyrrolidone and cinnamic alcohol in water, blending to emulsify, and then drying to solid form at about room temperature, with the cinnamic alcohol serving as said bactericidal component.
    [5" id="US-20010006669-A1-CLM-00005] 5. The method as claimed in
    claim 4 wherein tannic acid is added to said mixture before blending to emulsify
    [6" id="US-20010006669-A1-CLM-00006] 6. The method as claimed in
    claim 5 wherein the weight percentages of the constituents of the solidified emulsion are substantially within the ranges polyvinylpyrrolidone, 82-90%, cinnamic alcohol, 3-15%, and tannic acid, 3-12%
    [7" id="US-20010006669-A1-CLM-00007] 7. The method as claimed in
    claim 6 wherein the polyvinylpyrrolidone is provided in water solution and the cinnamic alcohol is added in liquid form.
    [8" id="US-20010006669-A1-CLM-00008] 8. The method as claimed in
    claim 4 wherein an alcohol or aqueous solution of iodine is added to the mixture and becomes solidified in the dried emulsion
    [9" id="US-20010006669-A1-CLM-00009] 9. The method as claimed in
    claim 8 wherein the weight percentage of the iodine is substantially in the range ½-3%
    [10" id="US-20010006669-A1-CLM-00010] 10. The method of
    claim 1 wherein the heat and moisture are applied by steam.
    [11" id="US-20010006669-A1-CLM-00011] 11. In the preparation and use of a normally room-temperature-stored normally dry bactericidal-component-dispersed solid emulsion complex for pharmacological use with bleeding cuts and abrasions, and that remains solidified at room temperature and below and so long as it is not contacted by moisture, but that starts to liquefy at somewhat higher temperature of the order of the temperature of human or animal blood in a living subject upon application of moisture thereupon, a method of rendering antiseptic the exposed surface of the solidified emulsion before use, that comprises, treating the complex with one or both of, increased temperature at least to said higher temperature, and moisture applied to said exposed surface, but only for a time interval that is limited to the time required for the commencement of liquefying of said component to wet the exposed surface of the solidified emulsion drawn therefrom, and with a concurrent resulting commencement or release of bactericidal vapor phase therefrom, thereby to coat the exposed surface with the bactericidal component liquid drawn from the emulsion
    [12" id="US-20010006669-A1-CLM-00012] 12. The method claimed in
    claim 11 wherein said solidified emulsion is formed by dissolving a mixture comprising polyvinylpyrrolidone and cinnamic alcohol in water, blending to emulsify, and then drying to solid form at about room temperature, with the cinnamic alcohol serving as said bactericidal component.
    [13" id="US-20010006669-A1-CLM-00013] 13. The method as claimed in
    claim 12 wherein tannic acid is added to said mixture before blending to emulsify.
    [14" id="US-20010006669-A1-CLM-00014] 14. The method as claimed in
    claim 13 wherein the weight percentages of the constituents of the solidified emulsion are substantially within the ranges polyvinylpyrrolidone, 82-90%, cinnamic alcohol, 3-15%, and tannic acid, 3-12%
    [15" id="US-20010006669-A1-CLM-00015] 15. The method as claimed in
    claim 12 wherein an alcohol or aqueous solution of iodine is added to the mixture and becomes solidified in the dried emulsion.
    [16" id="US-20010006669-A1-CLM-00016] 16. The method as claimed in
    claim 15 wherein the weight percentage of the iodine is substantially in the range: ½-3%
    [17" id="US-20010006669-A1-CLM-00017] 17. An antiseptic sealed package of solid dry admixed polyvinylpyrrolidone—cinnamic alcohol—tannic acid emulsion complex wherein the external surface of the emulsion carries a coating of cinnamic alcohol liquefied from the solid emulsion and then dried thereupon, and the interior of the package has been exposed to vaporized cinnamic alcohol.
    [18" id="US-20010006669-A1-CLM-00018] 18. The complex of
    claim 17 comprising about 82-90% polyvinylpyrrolidone, 3-15% cinnamic alcohol and 3-12% tannic acid, by weight
    [19" id="US-20010006669-A1-CLM-00019] 19. The complex of
    claim 17 wherein there is further present about ½-3% iodine, by weight
    [20" id="US-20010006669-A1-CLM-00020] 20. The complex of
    claim 18 wherein the complex is coated on a bandage substrate sealed within said package.
    [21" id="US-20010006669-A1-CLM-00021] 21. The complex of
    claim 19 wherein the complex is coated on a swab sealed within said package.
    [22" id="US-20010006669-A1-CLM-00022] 22. The complex of
    claim 18 wherein the complex is in powdered form within the sealed package
    [23" id="US-20010006669-A1-CLM-00023] 23. The complex of
    claim 19 wherein the complex is in powdered form within the sealed package.
    [24" id="US-20010006669-A1-CLM-00024] 24. An antiseptic sealed package of solid dry admixed polyvinylpyrrolidone—cinnamic alcohol—iodine emulsion complex wherein the external surface of the emulsion carries a coating of cinnamic alcohol liquefied from the solid emulsion and then dried thereupon, and the interior of the package has been exposed to vaporized cinnamic alcohol
    [25" id="US-20010006669-A1-CLM-00025] 25. The complex of
    claim 24 comprising about 82-90% polyvinylpyrrolidone, 3-15% cinnamic alcohol and ½-3% iodine, by weight
    [26" id="US-20010006669-A1-CLM-00026] 26. An antiseptic product of solid dry admixed polyvinylpyrrolidone—cinnamic alcohol emulsion complex wherein the external surface of the emulsion carries a coating of cinnamic alcohol liquefied from the solid emulsion and then dried thereupon and sealing the surface
    [27" id="US-20010006669-A1-CLM-00027] 27. The antiseptic product of
    claim 26 wherein the emulsion complex further contains iodine solidified therein
    [28" id="US-20010006669-A1-CLM-00028] 28. An antiseptic solid dry admixed polyvinylpyrrolidone—cinnamic alcohol emulsion complex wherein the external surface of the emulsion carries a coating sealed thereover of cinnamic alcohol liquefied from the solid emulsion and then dried thereupon
    [29" id="US-20010006669-A1-CLM-00029] 29. The complex of
    claim 28 wherein the emulsion further contains iodine within the dry complex
    [30" id="US-20010006669-A1-CLM-00030] 30. The complex of claim comprising about 82-90% polyvinylpyrrolidone, 3-15% cinnamic alcohol and ½-3% iodine, by weight
    [31" id="US-20010006669-A1-CLM-00031] 31. The complex of
    claim 30 wherein the complex further contains one or more of the group consisting of tannic acid, cortisone, benzocaine, xylocaine, and benzalkonium chloride.
    类似技术:
    公开号 | 公开日 | 专利标题
    JP3827743B2|2006-09-27|Pretreatment of skin surface for surgical procedures
    US4391799A|1983-07-05|Protective gel composition for treating white phosphorus burn wounds
    AU716244B2|2000-02-24|Sterilisable paste product for topical application
    US3751562A|1973-08-07|Medicated gelled oils
    JP4450871B2|2010-04-14|Formulation composition for skin surface of surgical site
    US4434181A|1984-02-28|Teat dip
    CA1145082A|1983-04-19|Covering material
    JP3000104B2|2000-01-17|Compositions and methods for forming a film at native sites on body tissue
    EP0391741B1|1995-04-19|Polymeric broad-spectrum antimicrobial materials
    CA2011826A1|1990-10-10|Film-forming emulsion containing iodine and methods of use
    DE60101956T2|2004-12-23|FOAMING Wound Bandage
    GB2236676A|1991-04-17|Antimicrobial hydroxyapatite powders
    JP2004516864A|2004-06-10|Methods of treating burns on mammalian skin to reduce the risk of infection and minimize fluid loss
    IE43853B1|1981-06-17|Antiseptic compositions
    EP0472575A1|1992-03-04|Improvements in or relating to pharmaceutical preparations
    US6444219B2|2002-09-03|Antiseptic packaged polyvinylpyrrolidone-cinnamic alcohol solid products and the like and method of preparing the same
    US20030060380A1|2003-03-27|Bio-compatible remover composition for removing medical grade and other adhesives, and kit including the same
    HU200103B|1990-04-28|Process for producing pharmaceutical compositions for treating lack of epithelium
    CA2102352A1|1994-08-24|Medicinal salve composition
    CA3081695A1|2019-05-09|Radiation sterilized hydrogels, medical devices including radiation sterilized hydrogels and methods of making the same
    HU201683B|1990-12-28|Process for producing pharmaceutical compositions for promoting healing of wounds
    PT1689338E|2013-04-18|Antimicrobial adhesive system
    KR950013759B1|1995-11-15|Phamaceutical agent for promoting wound-healing
    US5653994A|1997-08-05|Composition and methods for treating burns and other trauma of the skin
    US3950261A|1976-04-13|Anhydrous liquid iodophor solution
    同族专利:
    公开号 | 公开日
    US6444219B2|2002-09-03|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2003007908A2|2001-07-17|2003-01-30|Beiersdorf Ag|Cosmetic or dermatological preparations having a long-term cooling action|
    WO2016042406A1|2014-09-19|2016-03-24|Galia Textil|Impregnated dry substrates for a dressing material, method and system for manufacturing the same|US3525340A|1967-10-31|1970-08-25|Joseph G Gilbert|Surgical dressing with skin clips thereon|
    US3777016A|1967-10-31|1973-12-04|J Gilbert|Composition and method for the treat-ment of damaged skin|
    US4094967A|1976-10-22|1978-06-13|Allor Foundation|Iodine-polyvinylpyrrolidone solid product and method of preparation|US7232573B1|2002-09-26|2007-06-19|Advanced Cardiovascular Systems, Inc.|Stent coatings containing self-assembled monolayers|
    KR100677766B1|2003-11-28|2007-02-05|주식회사 하이닉스반도체|Semiconductor device with trench type isolation and method for making the same|
    US20080128425A1|2006-12-01|2008-06-05|Donald Rick|Self-warming analgesic composition in a dual chamber bottle|
    US20080128426A1|2006-12-01|2008-06-05|Donald Rick|Self-warming sanitizing composition in a dual chamber bottle|
    法律状态:
    1998-10-26| AS| Assignment|Owner name: ALLOR FOUNDATION, NEW HAMPSHIRE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RINES, ROBERT H.;RINES, R. DAVID;REEL/FRAME:009543/0596 Effective date: 19981008 |
    2006-02-03| FPAY| Fee payment|Year of fee payment: 4 |
    2010-04-12| REMI| Maintenance fee reminder mailed|
    2010-09-03| LAPS| Lapse for failure to pay maintenance fees|
    2010-10-04| STCH| Information on status: patent discontinuation|Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
    2010-10-26| FP| Expired due to failure to pay maintenance fee|Effective date: 20100903 |
    优先权:
    申请号 | 申请日 | 专利标题
    US09/169,756|US6444219B2|1998-10-09|1998-10-09|Antiseptic packaged polyvinylpyrrolidone-cinnamic alcohol solid products and the like and method of preparing the same|US09/169,756| US6444219B2|1998-10-09|1998-10-09|Antiseptic packaged polyvinylpyrrolidone-cinnamic alcohol solid products and the like and method of preparing the same|
    [返回顶部]